2-203870886-C-T
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_005214.5(CTLA4):c.410C>T(p.Pro137Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000000684 in 1,461,852 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_005214.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461852Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727224
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency Pathogenic:3
Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 432079). This missense change has been observed in individuals with clinical features of CTLA4 haploinsufficiency (PMID: 26884280, 27102614, 27577878, 30377434, 30940614; Invitae). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 137 of the CTLA4 protein (p.Pro137Leu). For these reasons, this variant has been classified as Pathogenic. -
The variant is observed at an extremely low frequency in the gnomAD v4.0.0 dataset (total allele frequency: <0.001%). n silico tool predictions suggest damaging effect of the variant on gene or gene product [3Cnet: 0.86 (>=0.6, sensitivity 0.72 and precision 0.9)]. The same nucleotide change resulting in the same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000432079). The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID: 26884280, 27102614, 27577878, 30377434, 30940614). A different missense change at the same codon (p.Pro137Arg) has been reported to be associated with CTLA4-related disorder (ClinVar ID: VCV000827701 / PMID: 27102614). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. -
ACMG classification criteria: PS4 moderate, PM2, PM5, PP1 moderate, BP4 supporting -
Systemic lupus erythematosus;C0677607:Hashimoto thyroiditis;C1832392:Type 1 diabetes mellitus 12;C1857845:Celiac disease, susceptibility to, 3;C4015214:Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency Pathogenic:1
CTLA4 NM_005214.4 exon 2 p.Pro137Leu (c.410C>T): This variant has been reported in the literature in at least 2 individuals with immunodeficiency, 1 of whom presented with a complex phenotype including autoimmune cytopenias, enteropathy, pancreatic insufficiency, diabetes and renal insufficiency (Slatter 2016 PMID:27102614, Stray-Pederson 2016 PMID:27577878). This variant is not present in large control databases. This variant is present in ClinVar (Variation ID:432079). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. Of note, other variants at this codon have been reported in association with disease (p.Pro137Arg, p.Pro137Gln) suggesting that this region has significance. In summary, data on this variant is highly suspicious for disease, but requires further evidence for pathogenicity. Therefore, this variant is classified as likely pathogenic. -
not provided Pathogenic:1
The P137L variant in the CTLA4 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The P137L variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The P137L variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, we interpret P137L as a likely pathogenic variant -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at